Nanoparticle vaccine shown to block range of flu strains in pre-clinical study
A new vaccine formulated with nanoparticles protected animal models from a variety of seasonal and pandemic influenza strains.
List view / Grid view
A new vaccine formulated with nanoparticles protected animal models from a variety of seasonal and pandemic influenza strains.
Five immune response biomarkers have been identified by researchers who say they can be used to classify which COVID-19 patients will survive the disease.
An antibody called S309, identified in a blood sample from a SARS patient, inhibits related coronaviruses, including SARS-CoV-2, researchers have found.
A study has shown that the sensor of a DNA sensing pathway, DNA-PK, could act as an antiviral against tumours.
Researchers have shown that a monoclonal antibody prevents viruses from fusing with cell membranes to gain entry.
Advance paves the way for the design of transmembrane proteins with useful new functions...